Fu D Y, Lu X M, Yu Y L, Zhao L D, Wang L, Yang J, Zheng J W, Wang D Y, Yang L H, Wang G
Department of Hematology, The Sencond Hospital of Shanxi Medical University, Center for Shanxi Medical University and Tumor of the Hematopoietic and Lymphoid Tissues Diseases, Shanxi Provincial Key Laboratory for Molecular Diagnosis and Treatment of Hematological Diseases, Taiyuan 030001, China.
Zhonghua Xue Ye Xue Za Zhi. 2024 Oct 14;45(10):902-908. doi: 10.3760/cma.j.cn121090-20240506-00169.
To analyze the F10 gene mutations in a Chinese pedigree affected with the deficiency of the hereditary coagulation factor X (FX), resulting from a new deletion mutation, and to study the associated molecular pathogenesis. Next generation sequencing (NGS) was performed to screen the genetic mutations in the proband which were then verified by Sanger sequencing. The FX activity (FX∶C) of probands and their family members was detected using the blood clotting method, and the mutation sites of the family members were analyzed using Sanger sequencing. The pathogenicity of the mutation site was predicted by using the online bioinformatics software, Mutation Taster. The SWISS-MODEL software was used for stimulating the three-dimensional models of the wild-type and mutant proteins for analyzing the influence of the mutation site on the structure and function of the proteins, and for analyzing the difference between the catalytic residues of the wild-type and the mutant proteins. The level of the F10 gene mRNA was quantitatively analyzed by qRT-PCR (quantitative reverse transcription polymerase chain reaction) method by constructing plasmids, transfecting human embryonic kidney 293T cells (HEK 293T), and analyzing the splicing of the mutated site by RT-PCR method. The levels of FⅩ∶Ag in cell lysates and cell culture media (both inside and outside the cells) were detected by the ELISA (enzyme linked immunosorbent assay) method. A medium-grade factor X deficiency with a 36.42% FⅩ∶C ratio was detected in the proband by the coagulation method. NGS analysis demonstrated a heterozygous deletion mutation in exon 8:c.902_919del (p.Ala301_Glu306del) in the proband. Sanger sequencing analysis indicated that some members of the family (mother and grandfather) were also carriers of the corresponding deletion mutation. Online bioinformatics software predicted the pathogenic nature of the c.902_919del mutation, with a pathogenic score of 0.999. The 3D protein structure model analysis indicated that the c.902_919del mutation resulted in the disappearance of a segment of β-fold in the protein structure, thereby shortening the preceding segment of the β-fold and a subsequent loss of hydrogen bonds between adjacent amino acids with no significant difference in the side chain conformation of the key catalytic residues compared to the wild-type. mRNA splicing analysis indicated the absence of alternative splicing changes in the mutation, and qRT-PCR results indicated the absence of a statistically significant difference between the mRNA levels of F10 gene and wild-type mRNA in cells expressing c.902_919del mutant. The ELISA results indicated that there was no statistically significant difference in the FX∶Ag levels of the mutant cell culture medium and the lysate. In this pedigree, the heterozygous mutation in exon 8 of F10 gene (c.902_919del, p.Ala301_Glu306del) caused the hereditary factor Ⅹ deficiency.
分析一个因新的缺失突变导致遗传性凝血因子X(FX)缺乏的中国家系中的F10基因突变,并研究相关的分子发病机制。采用二代测序(NGS)筛选先证者中的基因突变,然后用桑格测序进行验证。采用凝血法检测先证者及其家庭成员的FX活性(FX∶C),并用桑格测序分析家庭成员的突变位点。利用在线生物信息学软件Mutation Taster预测突变位点的致病性。使用SWISS-MODEL软件模拟野生型和突变型蛋白的三维模型,分析突变位点对蛋白结构和功能的影响,以及野生型和突变型蛋白催化残基之间的差异。通过构建质粒、转染人胚肾293T细胞(HEK 293T),采用qRT-PCR(定量逆转录聚合酶链反应)方法定量分析F10基因mRNA水平,并用RT-PCR方法分析突变位点的剪接情况。采用ELISA(酶联免疫吸附测定)法检测细胞裂解液和细胞培养基(细胞内外)中FⅩ∶Ag的水平。通过凝血法在先证者中检测到中度因子X缺乏,FⅩ∶C比值为36.42%。NGS分析显示先证者外显子8存在杂合缺失突变:c.902_919del(p.Ala301_Glu306del)。桑格测序分析表明该家系的一些成员(母亲和祖父)也是相应缺失突变的携带者。在线生物信息学软件预测c.902_919del突变具有致病性,致病评分为0.999。三维蛋白结构模型分析表明,c.902_919del突变导致蛋白结构中一段β折叠消失,从而缩短了β折叠的前段,相邻氨基酸之间的氢键随后丢失,与野生型相比,关键催化残基的侧链构象无显著差异。mRNA剪接分析表明该突变不存在可变剪接变化,qRT-PCR结果表明在表达c.902_919del突变体的细胞中,F10基因mRNA水平与野生型mRNA水平之间无统计学显著差异。ELISA结果表明突变细胞培养基和裂解液中FX∶Ag水平无统计学显著差异。在这个家系中,F10基因外显子8的杂合突变(c.902_919del,p.Ala301_Glu306del)导致遗传性因子Ⅹ缺乏。